Advancements in Sacroiliac Joint Dysfunction Treatment: The Need for Protocol Shifts for h-EDS/HSD Patients Driven by a new SIJ Fusion Procedure
Speaker Credentials
MDI
Speaker Credentials
MS
College
College of Allopathic Medicine
Medical Specialty
Orthopedic Surgery
Format
Poster
Start Date
November 2024
End Date
November 2024
Track
3
Abstract
Objective: This narrative review examines advancements in sacroiliac joint (SIJ) dysfunction treatments and current protocols, focusing on patients with hypermobile Ehlers-Danlos Syndrome (h-EDS) and hypermobility spectrum disorders (HSD), while also considering other related pathologies. Background: SIJ dysfunction is common in patients with h-EDS and HSD, often causing lower back and pelvic pain, dislocations, and subluxations. Treatments are usually non-surgical and continuous regimens. Over the last 15 years, SIJ fusion has shown notable improvements in pain relief, disability reduction, and recovery times. The new iFUSE Implant System is engineered to minimize patient risk while providing enhanced joint stability. Current treatment protocols, however, still recommend surgery only as a last resort, leaving many patients with years of ineffective treatments. Methods: Peer-reviewed studies from the past 20 years on SIJ dysfunction treatments were reviewed, focusing on patients with h-EDS/HSD. Additionally, a broader set of data from the general population treated for SIJ dysfunction was examined to provide a more comprehensive clinical perspective. Results: The minimally invasive iFUSE SIJ fusion demonstrated significantly improved pain, disability, and quality of life scores compared to other treatments. Adverse events occurred at a low rate and most resolved quickly. These results were consistent across both patient groups. Conclusion: SIJ dysfunction is prevalent in h-EDS/HSD patients, who often lack adequate relief under current protocols. The success of SIJ fusion treatments indicates a need to update these protocols to enhance patient outcomes. Grants: This was an unfunded study.
Advancements in Sacroiliac Joint Dysfunction Treatment: The Need for Protocol Shifts for h-EDS/HSD Patients Driven by a new SIJ Fusion Procedure
Objective: This narrative review examines advancements in sacroiliac joint (SIJ) dysfunction treatments and current protocols, focusing on patients with hypermobile Ehlers-Danlos Syndrome (h-EDS) and hypermobility spectrum disorders (HSD), while also considering other related pathologies. Background: SIJ dysfunction is common in patients with h-EDS and HSD, often causing lower back and pelvic pain, dislocations, and subluxations. Treatments are usually non-surgical and continuous regimens. Over the last 15 years, SIJ fusion has shown notable improvements in pain relief, disability reduction, and recovery times. The new iFUSE Implant System is engineered to minimize patient risk while providing enhanced joint stability. Current treatment protocols, however, still recommend surgery only as a last resort, leaving many patients with years of ineffective treatments. Methods: Peer-reviewed studies from the past 20 years on SIJ dysfunction treatments were reviewed, focusing on patients with h-EDS/HSD. Additionally, a broader set of data from the general population treated for SIJ dysfunction was examined to provide a more comprehensive clinical perspective. Results: The minimally invasive iFUSE SIJ fusion demonstrated significantly improved pain, disability, and quality of life scores compared to other treatments. Adverse events occurred at a low rate and most resolved quickly. These results were consistent across both patient groups. Conclusion: SIJ dysfunction is prevalent in h-EDS/HSD patients, who often lack adequate relief under current protocols. The success of SIJ fusion treatments indicates a need to update these protocols to enhance patient outcomes. Grants: This was an unfunded study.